This one has a reasonably settled answer, so here it is. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
What would genuinely help is knowing how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Numbers rather than impressions, if you have them.
RetaRick_CA said:It helps to say which part of this you are uncertain about.
That holds where the measurement is reliable. Where it is noisy — and a lot of what gets tracked here is noisy — the same reasoning produces confident nonsense.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultsmona_PHX said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Can confirm. Same sequence, different timescale. Nothing to add that would improve it.
Clinical perspective, offered as context rather than as advice. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.
Ask again with the specifics and you will get a better answer than this one.